A Study of Cabazitaxel for Patients With Breast or Lung Cancer and Recurrent or Progressive Brain Metastases - Cabazitaxel for Brain Metastases (CaBaMet)
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Lung Cancer|Recurrent Brain Metastases|Progressive Brain Metastases
Interventions: DRUG: Cabazitaxel
Sponsor: AIO-Studien-gGmbH
Collaborators: ClinAssess GmbH|Sanofi